Feb 6, 2014· Comment from American Pharmacists Association (APhA)· FDA-2013-D-1444-0029
Attached please find the comments of the American Pharmacists Association (APhA) on the draft 503A Guidance.
FDANonrulemakingFDA-2013-D-1444
Pharmacy Compounding of Human Drug Products under Section 503A of the Federal Food, Drug, and Cosmetic Act
RIN
—
Last modified
Jan 5, 2017
Comment window
closed 4658d ago
American Pharmacists Association (APhA) filings
1
Activity
American Pharmacists Association (APhA) filed 1 comment on this docket between Feb 6, 2014 and Feb 6, 2014. 7 other organizations filed here. The comment window closed 4658d ago.
What American Pharmacists Association (APhA) filed (1)
Abstract
No abstract recorded.
View on regulations.gov →Co-filers (7)
See everyone who commented →- American Pharmacists Association (APhA)THIS ORG1 filing · confidence 97%
- Alliance for Natural Health USAtrade assoc.2 filings · confidence 85%
- American Association of Naturopathic Physicianstrade assoc.2 filings · confidence 85%
- American Society of Health-System Pharmaciststrade assoc.1 filing · confidence 85%
- and Public Health Coalitiontrade assoc.1 filing · confidence 85%
- National Association of Chain Drug Storestrade assoc.1 filing · confidence 97%
- National Community Pharmacists Associationtrade assoc.1 filing · confidence 97%
- National Home Infusion Associationtrade assoc.1 filing · confidence 85%